Eurazeo Capital completed the acquisition of Dutch Ophthalmic Research Centre from Montagu.

Eurazeo Capital has entered into exclusive discussions with Montagu Private Equity completed the acquisition of DORC (Dutch Ophthalmic Research Centre) for c. €300m ($339m). “The acquisition of DORC fits perfectly with our investment strategy to support growing businesses with strong international development potential as they scale up. Widely recognized as innovative and best in a class by surgeons across the world, the Company delivers remarkable financial performance. We expect to leverage our international network to accelerate DORC’s growth.” Marc Frappier, Eurazeo Capital Managing Partner, and Head.